For the six months ended June 30, 2007, China Medical System Holdings' sales increased 37% on the comparable period last year, to $24.0 million, as gross profit jumped 26% to $15.7 million.
These figures represent its maiden interim results following a successful listing on the Alternative Investment Market of the London Stock Exchange in June 2007, raising $10.0 million gross for the company. Net profit for the period before intial public offering costs and employee benefits recognized, increased 57% to $5.4 million and represents an adjusted net margin on sales of 22% versus 20%.
The firm noted that its selling and marketing expenses have increased to $6.5 million vs $5.6 million in line with its budget, resulting from the introduction of new products to the market during the half year.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze